The ClC-1 chloride channel inhibitor NMD670 improves skeletal muscle function in rat models and patients with myasthenia gravisMartin Skov, Thomas Holm Pedersen, Anders Riisager et al.|Science Translational Medicine|2024Cited by 31
Role of recovery of acetylcholine release in compromised neuromuscular junction functionJeppe Blichfeldt Winther, Thomas Holm Pedersen, Jeanette J. Morgen et al.|Neuromuscular Disorders|2024Cited by 4